Tempest Therapeutics, Inc., 2026-10-14
A new SEC Form D private-offering notice from Brisbane, CA, a $7,500,000 filer-stated offering target in Biotech. The source filing is one click away.
What this filing says
Clinical-stage biotech (NASDAQ: TPST) developing small-molecule cancer therapeutics combining tumor-targeted and immune-mediated mechanisms.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Circularity Fuels, Inc., 2026-10-14, $10.2M, Redwood City, CA
- Myris Therapeutics, Inc., 2026-10-14, $4.5M, Sharpsburg, PA
- Safi Analytics PBC, 2026-10-14, $25M, San Francisco, CA
- Kaigene, Inc., 2026-10-14, $73.3M, Rockville, MD
- GEN Restaurant Group, Inc., 2026-10-14, $25M, Cerritos, CA
- Hypercell Technologies Inc., 2026-10-14, $4.4M, Ithaca, NY
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.